Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
The current Pfizer(PFE) stock price is $26.49, with a market capitalization of 151.63B. The stock trades at a price-to-earnings (P/E) ratio of 20.28 and offers a dividend yield of 6.5%.
On 2026-05-07, Pfizer(PFE) stock traded between a low of $26.21 and a high of $26.68. Shares are currently priced at $26.49, which is +1.1% above the low and -0.7% below the high.
The Pfizer(PFE)'s current trading volume is 40.36M, compared to an average daily volume of 40.5M.
In the last year, Pfizer(PFE) shares hit a 52-week high of $28.75 and a 52-week low of $21.97.
In the last year, Pfizer(PFE) shares hit a 52-week high of $28.75 and a 52-week low of $21.97.
PFE News
Key Points Pfizer has a long and successful history of developing new and profitable drugs. General Mills focuses on industry-leading brands and has often adj...
Novavax (NVAX) shares added ~6% in the premarket on Wednesday after the COVID-19 vaccine maker well exceeded Street forecasts with its Q1 financials, thanks to...
Analyst Terence Flynn from Morgan Stanley maintained a Hold rating on Pfizer and keeping the price target at $28.00. Unlock hedge fund-level data and powerful...
Analyst ratings
50%
of 30 ratingsMore PFE News
Pfizer Inc ((PFE)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock hedge fund-level data and powerful...
FDA approves VEPPANU (vepdegestrant), co developed by Arvinas and Pfizer, as the first PROTAC protein degrader therapy for advanced ER+/HER2, ESR1 mutated breas...
Pfizer (PFE) expects to return to consistent growth by 2029, targeting high-single-digit annual revenue increases through 2033, supported by a predictable post-...
AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX AD...
This positive momentum comes alongside a broader market environment where S&P 500 futures are gaining by 0.4%, suggesting a favorable tone for equities overall....
Pfizer reports Q1 results above consensus, reaffirms 2026 guidance Pfizer rose in premarket trading after it reported earnings results that beat Wall Street ex...
Pfizer’s (PFE) shares rose over 2% early Tuesday after the American pharma giant released first-quarter 2026 earnings results that surpassed the Wall Street con...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.